Home › Chronic Lymphocytic Leukemia › Rhode Island › Providence

Chronic Lymphocytic Leukemia clinical trials in Providence, RI

5 studies for Chronic Lymphocytic Leukemia are looking for participants at sites in and around Providence (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

RecruitingPhase 3

Rhode Island Hospital, Providence

Ages 65 and older · All sexes · Updated Nov 3, 2026 · NCT07321652

A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies

RecruitingPhase 1/2

Research Site, Providence

Ages 18 and older · All sexes · Updated Oct 28, 2026 · NCT06564038

Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)

RecruitingPhase 1

Lifespan Cancer Institute at Rhode Island Hospital, Providence

Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT03666000

A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)

RecruitingPhase 3

Lifespan Cancer Institute - Providence /ID# 266550, Providence

Ages 18 and older · All sexes · Updated Apr 9, 2026 · NCT06428019

Study of SGR-1505 in Mature B-Cell Neoplasms

RecruitingPhase 1

Rhode Island Hospital, Providence

Ages 18 and older · All sexes · Updated Feb 13, 2026 · NCT05544019

Chronic Lymphocytic Leukemia trials in other cities

Other studies in Providence

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.